A selective plasmin inhibitor, trans-aminomethylcyclohexanecarbonyl-l-(O-picolyl)tyrosine-octylamide (YO-2), induces thymocyte apoptosis

This publication has 33 references indexed in Scilit:

• Involvement of Histone Phosphorylation in Thymocyte Apoptosis by Protein Phosphatase Inhibitors
  IUBMB Life, 1999
• Plasmin Cleaves Tumor Necrosis Factor α Exodomain from Sheep Follicular Endothelium: Implication in the Ovulatory Process1
  Biology of Reproduction, 1999
• Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells
  Cell Death & Differentiation, 1998
• Involvement of histone hyperacetylation in triggering DNA fragmentation of rat thymocytes undergoing apoptosis
  FEBS Letters, 1996
• Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl.
  The Journal of Experimental Medicine, 1995
• Protease inhibitors: Role and potential therapeutic use in human cancer
  European Journal Of Cancer, 1994
• Urokinase receptor and colorectal cancer survival
  The Lancet, 1994
• Selective Inhibition of Dexamethasone-Induced Apoptosis in Rat Thymocytes by Herbimycin A
  Biochemical and Biophysical Research Communications, 1994
• Plasminogen activators and their inhibitors in non-small cell lung cancer. Low content of type 2 plasminogen activator inhibitor associated with tumor dissemination
  Cancer, 1994
• The content of urokinase-type plasminogen activator antigen as a prognostic factor in urinary bladder cancer
  International Journal of Cancer, 1992